251 related articles for article (PubMed ID: 29407983)
1. Novel enmein-type diterpenoid hybrids coupled with nitrogen mustards: Synthesis of promising candidates for anticancer therapeutics.
Gao X; Li J; Wang M; Xu S; Liu W; Zang L; Li Z; Hua H; Xu J; Li D
Eur J Med Chem; 2018 Feb; 146():588-598. PubMed ID: 29407983
[TBL] [Abstract][Full Text] [Related]
2. Novel hybrids of brefeldin A and nitrogen mustards with improved antiproliferative selectivity: Design, synthesis and antitumor biological evaluation.
Han T; Tian K; Pan H; Liu Y; Xu F; Li Z; Uchita T; Gao M; Hua H; Li D
Eur J Med Chem; 2018 Apr; 150():53-63. PubMed ID: 29524728
[TBL] [Abstract][Full Text] [Related]
3. Effective enmein-type mimics of clinical candidate HAO472: Design, synthesis and biological evaluation.
Hu X; Bai Z; Qiao J; Li H; Xu S; Wang X; Xu Y; Xu J; Hua H; Li D
Eur J Med Chem; 2019 Jun; 171():169-179. PubMed ID: 30921757
[TBL] [Abstract][Full Text] [Related]
4. Hydrogen sulfide releasing enmein-type diterpenoid derivatives as apoptosis inducers through mitochondria-related pathways.
Xu F; Gao X; Li H; Xu S; Li X; Hu X; Li Z; Xu J; Hua H; Li D
Bioorg Chem; 2019 Feb; 82():192-203. PubMed ID: 30326401
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, Cytotoxicity and Antimicrobial Activity of New Enmein-type Kauranoid Diterpenoid Derivatives.
Li D; Han T; Hu X; Tian K; Xu S; Zhou T; Cheng K; Li Z; Hua H; Xu J
Anticancer Agents Med Chem; 2017; 17(12):1679-1688. PubMed ID: 28403782
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen sulfide donating ent-kaurane and spirolactone-type 6,7-seco-ent-kaurane derivatives: Design, synthesis and antiproliferative properties.
Li H; Gao X; Huang X; Wang X; Xu S; Uchita T; Gao M; Xu J; Hua H; Li D
Eur J Med Chem; 2019 Sep; 178():446-457. PubMed ID: 31202992
[TBL] [Abstract][Full Text] [Related]
7. Enmein-type diterpenoid analogs from natural kaurene-type oridonin: Synthesis and their antitumor biological evaluation.
Li D; Xu S; Cai H; Pei L; Zhang H; Wang L; Yao H; Wu X; Jiang J; Sun Y; Xu J
Eur J Med Chem; 2013 Jun; 64():215-21. PubMed ID: 23644204
[TBL] [Abstract][Full Text] [Related]
8. Library construction and biological evaluation of enmein-type diterpenoid analogues as potential anticancer agents.
Li D; Xu S; Cai H; Pei L; Wang L; Wu X; Yao H; Jiang J; Sun Y; Xu J
ChemMedChem; 2013 May; 8(5):812-8. PubMed ID: 23520191
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, Biological Activity, and Apoptotic Properties of NO-Donor/Enmein-Type ent-Kauranoid Hybrids.
Li D; Hu X; Han T; Xu S; Zhou T; Wang Z; Cheng K; Li Z; Hua H; Xiao W; Xu J
Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27231893
[TBL] [Abstract][Full Text] [Related]
10. NO-Releasing Enmein-Type Diterpenoid Derivatives with Selective Antiproliferative Activity and Effects on Apoptosis-Related Proteins.
Li D; Hu X; Han T; Liao J; Xiao W; Xu S; Li Z; Wang Z; Hua H; Xu J
Molecules; 2016 Sep; 21(9):. PubMed ID: 27617998
[TBL] [Abstract][Full Text] [Related]
11. Bioactive enmein-type 6,7-seco-ent-kaurane diterpenoids: natural products, synthetic derivatives and apoptosis related mechanism.
Li H; Sun B; Wang M; Hu X; Gao X; Xu S; Xu Y; Xu J; Hua H; Li D
Arch Pharm Res; 2018 Nov; 41(11):1051-1061. PubMed ID: 30242610
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of novel sesquiterpene mustards as potential anticancer agents.
Xu YZ; Gu XY; Peng SJ; Fang JG; Zhang YM; Huang DJ; Chen JJ; Gao K
Eur J Med Chem; 2015 Apr; 94():284-97. PubMed ID: 25771034
[TBL] [Abstract][Full Text] [Related]
13. The conversion of oridonin to spirolactone-type or enmein-type diterpenoid: synthesis and biological evaluation of ent-6,7-seco-oridonin derivatives as novel potential anticancer agents.
Wang L; Li D; Xu S; Cai H; Yao H; Zhang Y; Jiang J; Xu J
Eur J Med Chem; 2012 Jun; 52():242-50. PubMed ID: 22483090
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative hydrogen sulfide releasing evodiamine derivatives and their apoptosis inducing properties.
Hu X; Jiao R; Li H; Wang X; Lyu H; Gao X; Xu F; Li Z; Hua H; Li D
Eur J Med Chem; 2018 May; 151():376-388. PubMed ID: 29635169
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of scutellarein derivatives with antiproliferative activity and selectivity through the intrinsic pathway.
Han T; Wang Y; Wang M; Li X; Cheng K; Gao X; Li Z; Bai J; Hua H; Li D
Eur J Med Chem; 2018 Oct; 158():493-501. PubMed ID: 30243153
[TBL] [Abstract][Full Text] [Related]
16. Novel anticancer oridonin derivatives possessing a diazen-1-ium-1,2-diolate nitric oxide donor moiety: Design, synthesis, biological evaluation and nitric oxide release studies.
Xu S; Wang G; Lin Y; Zhang Y; Pei L; Yao H; Hu M; Qiu Y; Huang Z; Zhang Y; Xu J
Bioorg Med Chem Lett; 2016 Jun; 26(12):2795-2800. PubMed ID: 27158140
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of novel nitrogen mustard-evodiamine hybrids with selective antiproliferative activity.
Hu X; Wang Y; Xue J; Han T; Jiao R; Li Z; Liu W; Xu F; Hua H; Li D
Bioorg Med Chem Lett; 2017 Nov; 27(22):4989-4993. PubMed ID: 29037951
[TBL] [Abstract][Full Text] [Related]
18. Oridonin derivatives as potential anticancer drug candidates triggering apoptosis through mitochondrial pathway in the liver cancer cells.
Luo D; Yi Y; Peng K; Liu T; Yang J; Liu S; Zhao W; Qu X; Yu W; Gu Y; Wan S
Eur J Med Chem; 2019 Sep; 178():365-379. PubMed ID: 31200238
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of spirolactone-type diterpenoid derivatives from kaurene-type oridonin with improved antiproliferative effects and their apoptosis-inducing activity in human hepatoma Bel-7402 cells.
Li D; Cai H; Jiang B; Liu G; Wang Y; Wang L; Yao H; Wu X; Sun Y; Xu J
Eur J Med Chem; 2013 Jan; 59():322-8. PubMed ID: 23274570
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of novel quinazoline nitrogen mustard derivatives as potential therapeutic agents for cancer.
Li S; Wang X; He Y; Zhao M; Chen Y; Xu J; Feng M; Chang J; Ning H; Qi C
Eur J Med Chem; 2013 Sep; 67():293-301. PubMed ID: 23871909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
